title: Benefit of angiotensin II receptor blockade in the treatment of posttransplant polycythemia in renal transplant recipients.
authors.affiliation: Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, Michigan 48202, USA.
authors.forename: W
authors.initials: W
authors.lastname: Kupin
authors.forename: K K
authors.initials: KK
authors.lastname: Venkat
authors.forename: M
authors.initials: M
authors.lastname: Goggins
authors.forename: M
authors.initials: M
authors.lastname: Abouljoud
authors.forename: F
authors.initials: F
authors.lastname: Escobar
authors.forename: M
authors.initials: M
authors.lastname: Mozes
mesh_terms: D000804:Angiotensin II; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D004656:Enalapril / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D016030:Kidney Transplantation; D017706:Lisinopril / Q000627:therapeutic use; D019808:Losartan; D008297:Male; D011086:Polycythemia / Q000188:drug therapy* / Q000209:etiology; D011183:Postoperative Complications; D013777:Tetrazoles / Q000627:therapeutic use*
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001713:Biphenyl Compounds; D007093:Imidazoles; D013777:Tetrazoles; D000804:Angiotensin II; D004656:Enalapril; D003404:Creatinine; D017706:Lisinopril; D019808:Losartan